597 results on '"Beger, Richard"'
Search Results
2. The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
3. Identification of structural factors that affect binding to cannabinoid receptor type 1
4. Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management
5. Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy
6. Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples
7. Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)
8. Metabolomics enables precision medicine: “A White Paper, Community Perspective”
9. Quantitative structure–toxicity relationships in translational toxicology
10. Determination of structural factors affecting binding to mu, kappa and delta opioid receptors
11. Distinct lipid signatures are identified in the plasma of rats with chronic inflammation induced by estradiol benzoate and sex hormones
12. Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants
13. Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice
14. Supplementary Table 1 from Comparison of Effects of Diet on Mammary Cancer: Efficacy of Various Preventive Agents and Metabolomic Changes of Different Diets and Agents
15. Supplementary Figure 1 from Comparison of Effects of Diet on Mammary Cancer: Efficacy of Various Preventive Agents and Metabolomic Changes of Different Diets and Agents
16. 3D-SDAR modeling of hERG potassium channel affinity: A case study in model design and toxicophore identification
17. Metabolomics evaluation of the impact of smokeless tobacco exposure on the oral bacterium Capnocytophaga sputigena
18. Targeted 13C-Labeled Tracer Fate Associations for Drug Efficacy Testing in Cancer
19. Computational identification of structural factors affecting the mutagenic potential of aromatic amines: study design and experimental validation
20. Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans
21. Evaluation of metabolism of azo dyes and their effects on Staphylococcus aureus metabolome
22. Targeted metabolomic profiling indicates structure-based perturbations in serum phospholipids in children with acetaminophen overdose
23. Acylcarnitines as Translational Biomarkers of Mitochondrial Dysfunction
24. Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
25. Towards quality assurance and quality control in untargeted metabolomics studies
26. Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards
27. Prediction and Experimental Evaluation of the hERG Blocking Potential of Drugs Showing Clinical Signs of Cardiotoxicity
28. Why are most phospholipidosis inducers also hERG blockers?
29. Quality assurance and quality control processes: summary of a metabolomics community questionnaire
30. Computational identification of a phospholipidosis toxicophore using 13C and 15N NMR-distance based fingerprints
31. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model
32. Metabolomics evaluation of the effects of green tea extract on acetaminophen-induced hepatotoxicity in mice
33. Evaluating effects of penicillin treatment on the metabolome of rats
34. Pharmacometabolomics in drug safety and drug-exposome interactions
35. NMR-Based Metabonomics in Toxicology Research
36. Translational biomarkers of acetaminophen-induced acute liver injury
37. Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs
38. Evaluating Cefoperazone-Induced Gut Metabolic Functional Changes in MR1-Deficient Mice
39. Metabolic fate of fructose in human adipocytes: a targeted 13C tracer fate association study
40. Serum metabolomic profiles from patients with acute kidney injury: A pilot study
41. Comprehensive analysis of alterations in lipid and bile acid metabolism by carbon tetrachloride using integrated transcriptomics and metabolomics
42. Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
43. Emerging technologies and their impact on regulatory science
44. Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology
45. Metabolomics as a Truly Translational Tool for Precision Medicine
46. Complementary PLS and KNN algorithms for improved 3D-QSDAR consensus modeling of AhR binding
47. Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children
48. Identification of metabolite profiles of the catechol- O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis
49. Discovery of early urinary biomarkers in preclinical study of gentamicin-induced kidney injury and recovery in rats
50. Metabolomics data and the biomarker qualification process
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.